Foresite Capital Opportunity Management V, Llc - Net Worth and Insider Trading

Over the past 18 months, Foresite Capital Opportunity Management V, Llc made no insider transaction in Kinnate Biopharma Inc (KNTE). Other recent insider transactions involving Kinnate Biopharma Inc (KNTE) include a net purchase of 2,866,100 shares made by Carl L Gordon , a net purchase of 2,866,100 shares made by Orbimed Advisors Llc , and a net purchase of 1,780,000 shares made by James B. Tananbaum .

In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 9,292,200 shares were bought by its insiders, resulting in a net purchase of 9,292,200 shares.

Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Foresite Capital Opportunity Management V, Llc made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 28,717 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 28,717 shares. During the past 18 months, 3,899,666 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,247,491 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Foresite Capital Opportunity Management V, Llc made no insider transaction in Pardes Biosciences Inc (PRDS). Other recent insider transactions involving Pardes Biosciences Inc (PRDS) include a net purchase of 50,000 shares made by Thomas G Wiggans , a net purchase of 773,952 shares made by Foresite Capital Fund V, L.p. , and a net purchase of 773,952 shares made by Foresite Capital Opportunity Fund V, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Pardes Biosciences Inc (PRDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pardes Biosciences Inc (PRDS) were sold and 2,256,324 shares were bought by its insiders, resulting in a net purchase of 2,256,324 shares.

Pardes Biosciences Inc (PRDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Foresite Capital Opportunity Management V, Llc made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 1,200,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 671,932 shares made by Carl L Gordon , and a net purchase of 671,932 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 2,557,866 shares were bought by its insiders, resulting in a net purchase of 2,557,866 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.